Terri Pustilnik

1.6k total citations · 1 hit paper
12 papers, 1.1k citations indexed

About

Terri Pustilnik is a scholar working on Molecular Biology, Genetics and Obstetrics and Gynecology. According to data from OpenAlex, Terri Pustilnik has authored 12 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Genetics and 3 papers in Obstetrics and Gynecology. Recurrent topics in Terri Pustilnik's work include Virus-based gene therapy research (3 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Sphingolipid Metabolism and Signaling (3 papers). Terri Pustilnik is often cited by papers focused on Virus-based gene therapy research (3 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Sphingolipid Metabolism and Signaling (3 papers). Terri Pustilnik collaborates with scholars based in United States, Spain and Puerto Rico. Terri Pustilnik's co-authors include David T. Curiel, Jon R. Wiener, Verónica Estrella, Gordon B. Mills, Astrid Eder, Weiping Zou, Frédérique Capron, Françoise Nomé, Alan N. Gordon and Roman Krzysiek and has published in prestigious journals such as Nature Medicine, Annals of the New York Academy of Sciences and Gynecologic Oncology.

In The Last Decade

Terri Pustilnik

12 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells

2001 509 citations Weiping Zou, Jozef Borvak et al. Nature Medicine profile →

Peers

Countries citing papers authored by Terri Pustilnik

Since Specialization

Citations

This map shows the geographic impact of Terri Pustilnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terri Pustilnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terri Pustilnik more than expected).

Fields of papers citing papers by Terri Pustilnik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terri Pustilnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terri Pustilnik. The network helps show where Terri Pustilnik may publish in the future.

Co-authorship network of co-authors of Terri Pustilnik

This figure shows the co-authorship network connecting the top 25 collaborators of Terri Pustilnik. A scholar is included among the top collaborators of Terri Pustilnik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Terri Pustilnik. Terri Pustilnik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Evaluation of insulin resistance among endometrial cancer patients 2012 ·Gynecologic Oncology ·Jennifer K. Burzawa, Kathleen M. Schmeler, Pamela T. Soliman, Robin A. Lacour, Larissa A. Meyer, Monica L. Huang, Michael W. Bevers, Michael Frumovitz, Terri Pustilnik, Jubilee Brown, Matthew L. Anderson, Lois M. Ramondetta, Guillermo Tortolero‐Luna, Diana L. Urbauer, Q. Zhang, Russell R. Broaddus, Shine Chang, David M. Gershenson, Kaizhi Lu	2
2	What women with ovarian cancer think and know about genetic testing 2008 ·Gynecologic Oncology ·Robin A. Lacour, Molly S. Daniels, Shannon N. Westin, Larissa A. Meyer, (unknown), Kimberly Burns, (unknown), (unknown), Terri Pustilnik, Karen H. Lu	54
3	Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathway 2007 ·International Journal of Oncology ·Verónica Estrella, Astrid Eder, Shuying Liu, Terri Pustilnik, Fazal H. Tabassam, François X. Claret, Gary E. Gallick, Gordon B. Mills, Jon R. Wiener	29
4	Cervical Concentrations of Interleukin-10 and Interleukin-12 Do Not Correlate with Plasma Levels 2002 ·Journal of Clinical Immunology ·Philip E. Castle, Allan Hildesheim, Frederick P. Bowman, Howard D. Strickler, Joan L. Walker, Terri Pustilnik, Robert P. Edwards, Peggy A. Crowley‐Nowick	38
5	An Immunomagnetic-Based Method for the Purification of Ovarian Cancer Cells from Patient-Derived Ascites 2001 ·Gynecologic Oncology ·Shannon Barker, Enrique Casado, Jesús Gómez-Navarro, Jialing Xiang, Waleed Arafat, Parameshwar J. Mahasreshti, Terri Pustilnik, Akseli Hemminki, Gene P. Siegal, Ronald D. Alvarez, David T. Curiel	34
6	Current strategies in gene therapy for ovarian cancer 2001 ·Current Opinion in Obstetrics & Gynecology ·Mack N. Barnes, Terri Pustilnik	7
7	Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells breakdown → 2001 ·Nature Medicine ·Weiping Zou, (unknown), (unknown), Jozef Borvak, Françoise Nomé, (unknown), Shuang Wei, Roman Krzysiek, Ingrid Durand–Gasselin, Alan N. Gordon, Terri Pustilnik, David T. Curiel, (unknown), Frédérique Capron, Dominique Émilie, Tyler J. Curiel	509
8	Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applications. 2001 ·PubMed ·Enrique Casado, Jesús Gómez-Navarro, Masato Yamamoto, Yasuo Adachi, (unknown), Waleed Arafat, Shannon Barker, (unknown), Parameshwar J. Mahasreshti, Akseli Hemminki, Manuel González-Barón, Mack N. Barnes, Terri Pustilnik, Gene P. Siegal, Ronald D. Alvarez, David T. Curiel	40
9	Adjuvant chemotherapy for high-risk endometrial cancer 2000 ·Seminars in Radiation Oncology ·Terri Pustilnik, Thomas W. Burke	19
10	Lysophospholipid Growth Factors in the Initiation, Progression, Metastases, and Management of Ovarian Cancer 2000 ·Annals of the New York Academy of Sciences ·Xianjun Fang, Douglas C. Gaudette, Tatsuro Furui, Muling Mao, Verónica Estrella, Astrid Eder, Terri Pustilnik, Takayo Sasagawa, (unknown), (unknown), Robert B. Jaffe, Jon R. Wiener, James R. Erickson, Gordon B. Mills	211
11	Lysophosphatidic acid 181 stimulates urokinase secretion in ovarian cancer cells 1999 ·Gynecologic Oncology ·Terri Pustilnik, Verónica Estrella, Jon R. Wiener, Gordon B. Mills	1
12	Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells. 1999 ·PubMed ·Terri Pustilnik, Verónica Estrella, Jon R. Wiener, Muling Mao, Astrid Eder, (unknown), Robert C. Bast, Gordon B. Mills	137

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact